New drug delivery nanosystem combining liposomal and dendrimeric technology (liposomal locked-in dendrimers) for cancer therapy

Journal of Pharmaceutical Sciences

Volumn 99, Issue 8, 2010, Pages 3561-3571

  Gardikis, Konstantinos ^a,b   Hatziantoniou, Sophia ^b   Bucos, Madalina ^a   Fessas, Dimitrios ^c   Signorelli, Marco ^c   Felekis, Theodoros ^a   Zervou, Maria ^a   Screttas, Constantinos G ^a   Steele, Barry R ^a   Ionov, Maksim ^d   Micha Screttas, Maria ^a   Klajnert, Barbara ^d   Bryszewska, Maria ^d   Demetzos, Costas ^b  

^a INSTITUTE OF BIOLOGY   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF LODZ   (Poland)

Author keywords

Dendrimer; Differential scanning calorimetry; Doxorubicin; Fluorescence spectroscopy; In vitro release; Liposome

Indexed keywords

DENDRIMER; DOXORUBICIN; LIPOSOME; POLYESTER; POLYETHER; 1,2-DIPALMITOYLPHOSPHATIDYLGLYCEROL; 1,2-OLEOYLPHOSPHATIDYLCHOLINE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; DRUG CARRIER; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL;

ANISOTROPY; ARTICLE; CANCER THERAPY; CHEMICAL ANALYSIS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; FLUORESCENCE SPECTROSCOPY; FREEZE DRYING; LIPID BILAYER; MEMBRANE FLUIDITY; PHYSICAL CHEMISTRY; THERMAL ANALYSIS; THERMOGRAPHY; CHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; NEOPLASMS; SOLUBILITY; SPECTROFLUOROMETRY;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; DENDRIMERS; DIFFERENTIAL THERMAL ANALYSIS; DOXORUBICIN; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; FREEZE DRYING; INDICATORS AND REAGENTS; LIPOSOMES; MEMBRANE FLUIDITY; NEOPLASMS; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS; SOLUBILITY; SPECTROMETRY, FLUORESCENCE;

EID: 77955113053     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22121     Document Type: Article

References (44)

1. Tekade RK, Kumar PV, Jain NK. 2009. Dendrimers in oncology: An expanding Horizon. Chem Rev 109:49-87.
2. Gullotti E, Yeo Y. 2009. Extracellularly activated nanocarriers: A new paradigm of tumor targeted drug delivery. Mol Pharm 6:1041-1051.
3. Abraham SA, Waterhouse DN, Mayer LD, Cullis PR, Madden TD, Bally MB. 2005. The liposomal formulation of doxorubicin. In: Nejat D, editor. Methods in enzymology, edition. San Diego, CA, USA: Elsevier Academic Press. pp. 71-97.
4. Massing U, Fuxius S. 2000. Liposomal formulations of anticancer drugs: Selectivity and effectiveness. Drug Resist Updates 3:171-177. (Pubitemid 30616502)
5. Schiffelers RM, Storm G. 2008. Liposomal nanomedicines as anticancer therapeutics: Beyond targeting tumor cells. Int J Pharm 364:258-264.
6. Hatziantoniou S, Dimas K, Georgopoulos A, Sotiriadou N, Demetzos C. 2006. Cytotoxic and antitumor activity of liposome-incorporated sclareol against cancer cell lines and human colon cancer xenografts. Pharmacol Res 53:80-87.
7. Miyajima K. 1997. Role of saccharides for the freeze-thawing and freeze drying of liposome. Adv Drug Deliv Rev 24:151-159. (Pubitemid 27112630)
8. Buhleier E, Wehner W, Vogtle F. 1978. Cascade-chain-like and nonskid-chain-like syntheses of molecular cavity topologies. Synthesis (Stuttgart) 2:155-158.
9. Tomalia DA, Naylor AM, Goddard WA. 1990. Starburst dendrimers-Molecular - level control of size, shape, surface-chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem Int Ed Engl 29:138-175.
10. Tomalia DA, Fréchet JMJ. 2002. Discovery of dendrimers and dendritic polymers: A brief historical perspective. J Polym Sci [A] 40:2719-2728.
11. Esfand R, Tomalia DA. 2001. Poly(amidoamine) (PAMAM) dendrimers: From biomimicry to drug delivery and biomedical applications. Drug Discov Today 6:427-436.
12. Gillies ER, Frechet JMJ. 2002. Designing macromolecules for therapeutic applications: Polyester dendrimer-poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture. J Am Chem Soc 124:14137-14146.
13. Gillies ER, Frechet JMJ. 2005. Dendrimers and dendritic polymers in drug delivery. Drug Discov Today 10:35-43.
14. Svenson S, Tomalia DA. 2005. Dendrimers in biomedical applications-reflections on the field. Adv Drug Deliv Rev 57:2106-2129.
15. Naylor AM, Goddard WA, Kiefer GE, Tomalia DA. 1989. Starburst dendrimers. 5. Molecular shape control. J Am Chem Soc 111:2339-2341.
16. Purohit G, Sakthivel T, Florence AT. 2001. Interaction of cationic partial dendrimers with charged and neutral liposomes. Int J Pharm 214:71-76.
17. Charrois GJR, Allen TM. 2004. Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer. Biochim Biophys Acta Biomembr 1663:167-177.
18. Drummond DC, Meyer O, Hong KL, Kirpotin DB, Papahadjopoulos D. 1999. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 51:691-743.
19. Khopade AJ, Caruso F, Tripathi P, Nagaich S, Jain NK. 2002. Effect of dendrimer on entrapment and release of bioactive from liposomes. Int J Pharm 232:157-162.
20. Papagiannaros A, Dimas K, Papaioannou GT, Demetzos C. 2005. Doxorubicin-PAMAM dendrimer complex attached to liposomes: Cytotoxic studies against human cancer cell lines. Int J Pharm 302:29-38.
21. Moraes ML, Baptista MS, Itri R, Zucolotto V, Oliveira ON, Jr. 2008. Immobilization of liposomes in nanostructured layer-by-layer films containing dendrimers. Mater Sci Eng C28:467-471.
22. Mecke A, Uppuluri S, Sassanella TM, Lee D-K, Ramamoorthy A, Baker JJR, Orr BG, Banaszak Holl MM. 2004. Direct observation of lipid bilayer disruption by poly(amidoamine) dendrimers. Chem Phys Lipids 132:3-14. (Pubitemid 39458316)
23. Hong S, Hessler JA, Banaszak Holl MM, Leroueil P, Mecke A, Orr BG. 2006. Physical interactions of nanoparticles with biological membranes: The observation of nanoscale hole formation. J Chem Health Saf 13:16-20.
24. Gardikis K, Hatziantoniou S, Viras K, Wagner M, Demetzos C. 2006. A DSC and Raman spectroscopy study on the effect of PAMAM dendrimer on DPPC model lipid membranes. Int J Pharm 318:118-123. (Pubitemid 43977802)
25. Klajnert B, Epand RM. 2005. PAMAM dendrimers and model membranes: Differential scanning calorimetry studies. Int J Pharm 305:154-166.
26. Klajnert B, Janiszewska J, Urbanczyk-Lipkowska Z, Bryszewska M, Epand RM. 2006. DSC studies on interactions between low molecular mass peptide dendrimers and model lipid membranes. Int J Pharm 327:145-152.
27. Moore JS, Stupp SI. 1990. Room temperature polyesterification. Macromolecules 23:65-70.
28. Nemoto H, Wilson JG, Nakamura H, Yamamoto Y. 1992. Polyols of a cascade type as a water-solubilizing element of carborane derivatives for boron neutron capture therapy. J Org Chem 57:435-435.
29. Rao TS, Revankar GR. 1995. Synthesis of Certain Acyclic Nucleoside Analogs of 1,2,4-Triazolo[3,4-f][1,2,4]triazine and Pyrimido[5,4-d]pyrimidine. Nucleosides Nucleotides Nucleic Acids 14:1601-1612.
30. Szoka F, Papahadjopoulos D. 1978. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA 75:4194-4198.
31. Wang N, Wang T, Li TF, Deng YJ. 2009. Modulation of the physicochemical state of interior agents to prepare controlled release liposomes. Colloids Surf B Biointerfaces 69:232-238.
32. Hatziantoniou S, Demetzos C. 2006. Qualitative and quantitative one-step analysis of lipids and encapsulated bioactive molecules in liposome preparations by HPTLC/FID (IATROSCAN). J Liposome Res 16:321-330.
33. Barone G, Del Vecchio P, Fessas D, Giancola C, Graziano G, 1992. Theseus: A new software package for the handling and analysis of thermal denaturation data of boilogical macromolecules. Journal of Thermal Analysis and Calorimetry 38:2279-2790.
34. Hupfeld S, Moen HH, Ausbacher D, Haas H, Brandl M. Liposome fractionation and size analysis by asymmetrical flow field-flow fractionation/multi-angle light scattering: Influence of ionic strength and osmotic pressure of the carrier liquid. Chem Phys Lipids 163:141-147.
35. Papagiannaros A, Hatziantoniou S, Dimas K, Papaioannou GT, Demetzos C. 2006. A liposomal formulation of doxorubicin, composed of hexadecylphosphocholine (HePC): Physicochemical characterization and cytotoxic activity against human cancer cell lines. Biomed Pharmacother 60:36-42. (Pubitemid 41821217)
36. Van Bommel EMG, Crommelin DJA. 1984. Stability of doxorubicin-liposomes on storage: As an aqueous dispersion, frozen or freeze-dried. Int J Pharm 22:299-310.
37. Fonseca M, vanWinden ECA, Crommelin DJA. 1997. Doxorubicin induces aggregation of small negatively charged liposomes. Eur J Pharm Biopharm 43:9-17.
38. Fritze A, Hens F, Kimpfler A, Schubert R, Peschka-Suss R. 2006. Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient. Biochim Biophys Acta Biomembr 1758:1633-1640.
39. vanWinden ECA, Crommelin DJA. 1997. Long term stability of freeze-dried, lyoprotected doxorubicin liposomes. Eur J Pharm Biopharm 43:295-307.
40. Tomalia DA. 2005. Birth of a new macromolecular architecture: Dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry. Prog Polym Sci 30:294-324.
41. Tomalia DA, Naylor AM, Goddard WA. 1990. Starburst dendrimers: Molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem Int Ed Engl 29:138-175.
42. Charrois GJR, Allen TM. 2004. Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer. Biochim Biophys Acta Biomembr 1663:167-177.
43. Ivanova VP, Makarov IM, Schaffer TE, Heimburg T. 2003. Analyzing heat capacity profiles of peptide-containing membranes: Cluster formation of gramicidin A. Biophys J 84:2427-2439.
44. Freire E, Markello T, Rigell C, Holloway PW. 1983. Calorimetric and fluorescence characterization of interactions between cytochrome b5 and phosphatidylcholine bilayers. Biochemistry 22:1675-1680.